Tracing the Spread of Clostridium difficile Ribotype 027 in Germany Based on Bacterial Genome Sequences by Steglich, Matthias et al.
RESEARCH ARTICLE
Tracing the Spread of Clostridium difficile
Ribotype 027 in Germany Based on Bacterial
Genome Sequences
Matthias Steglich1, Andreas Nitsche2, Lutz von Müller3¤, Mathias Herrmann3, Thomas
A. Kohl4, Stefan Niemann4,5, Ulrich Nübel6,7*
1 Robert Koch Institute, Department of Infectious Diseases, Division of Nosocomial Pathogens and Antibiotic
Resistances, Wernigerode, Germany, 2 Robert Koch Institute, Centre for Biological Threats and Special
Pathogens, ZBS 1 Highly Pathogenic Viruses, Berlin, Germany, 3 University of Saarland Medical Centre,
Institute of Medical Microbiology and Hygiene, National Consultant Laboratory for Clostridium difficile,
Homburg, Germany, 4 Research Center Borstel, Molecular Mycobacteriology, Borstel, Germany, 5 German
Center for Infection Research (DZIF), Partner Site Borstel, Borstel, Germany, 6 Leibniz Institute DSMZ,
Department of Microbial Genome Research, Braunschweig, Germany, 7 German Center for Infection
Research (DZIF), Partner Site Hannover-Braunschweig, Braunschweig, Germany




We applied whole-genome sequencing to reconstruct the spatial and temporal dynamics
underpinning the expansion of Clostridium difficile ribotype 027 in Germany. Based on re-
sequencing of genomes from 57 clinical C. difficile isolates, which had been collected from
hospitalized patients at 36 locations throughout Germany between 1990 and 2012, we
demonstrate that C. difficile genomes have accumulated sequence variation sufficiently
fast to document the pathogen's spread at a regional scale. We detected both previously
described lineages of fluoroquinolone-resistant C. difficile ribotype 027, FQR1 and FQR2.
Using Bayesian phylogeographic analyses, we show that fluoroquinolone-resistant C. diffi-
cile 027 was imported into Germany at least four times, that it had been widely disseminated
across multiple federal states even before the first outbreak was noted in 2007, and that it
has continued to spread since.
Introduction
Clostridium difficile is the most common cause of healthcare-associated diarrhea in Europe
and the USA [1, 2]. In 2009, C. difficile infection (CDI) was associated with almost 1% of
admissions to US hospitals, resulting in a severe burden of morbidity, mortality, and economic
costs [3]. In addition, community-associated CDI has been reported, albeit at a lower rate
[4–6].
The increase of CDI incidence observed in North America and Europe during the first
decade of this century was accompanied by the emergence of a previously uncommon strain of
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C. difficile [7, 8], genotyped as PCR ribotype 027, North American pulsotype NAP1, or restric-
tion endonuclease analysis type BI, respectively, depending on the genotyping method used
(for simplicity, we will refer to this strain as ribotype 027 throughout the remainder of this
paper). This epidemic strain caused large, highly publicized outbreaks in hospitals in Canada
[9], the US [10], and the UK [11], which were associated with elevated rates of mortality and
caused a change of awareness about CDI severity and epidemiology [12]. While conflicting evi-
dence exists regarding the increased virulence of epidemic ribotype 027 (reviewed in [13]), its
high-level resistance to fluoroquinolones may have facilitated its spread in healthcare facilities,
where this class of antibiotics is widely used [5, 10].
Population genomic analyses recently showed that, in fact, two distinct ribotype 027 line-
ages, dubbed FQR1 and FQR2, had emerged in North America, after independently acquiring
fluoroquinolone resistance in the 1990s [14]. Evidently, both lineages subsequently had spread
into Europe on multiple occasions, and either one of them was also found in Australia and
South Korea, respectively [14].
In Germany, cases of CDI with epidemic ribotype 027 were first reported in 2007 from a
hospital in Stuttgart [15] and from several hospitals around the city of Trier [16]. A nationwide
survey indicated that, by 2008, the dissemination of ribotype 027 was mostly restricted to the
southwest of Germany [17]. More recent data suggested that ribotype 027 is among the most
predominant C. difficile genotypes in Germany [6] and that its incidence may be increasing
[18, 19]. Clostridium difficile 027 was the most frequently isolated ribotype in a recent prospec-
tive survey across 20 European countries; however, 43% of ribotype 027 isolates in that study
had been found in samples from Germany alone [20]. Ribotype 027 isolates from Germany
commonly are highly resistant to fluoroquinolones [6, 17].
It is unclear, at present, to what extent each of the two internationally dispersed fluoroquin-
olone-resistant lineages, FQR1 and FQR2, contribute to the burden of CDI in Germany, and
what the dynamics of their spread among healthcare institutions may be. In the present study,
we generated genome sequence data from 57 C. difficile ribotype 027 isolates and analysed this
data in a Bayesian phylogeography framework to investigate the temporal dynamics of C. diffi-
cile spatial spread in Germany.
Results and Discussion
Phylogeny and population structure
Applying Illumina technology, we re-sequenced the genomes from 57 C. difficile ribotype 027
isolates, 56 of which had been collected from hospitalized patients at 35 locations in Germany
between 2007 and 2012, and one isolate had been isolated already in 1990 (S1 Table; sequences
were submitted to the European Nucleotide Archive, accession number PRJEB9067). In addi-
tion, we included 11 previously published genome sequences representing an international
context [14]. Sequencing reads were mapped onto the reference genome sequence from isolate
R20291 [14], which had been isolated during a large outbreak in the Stoke Mandeville hospital,
UK, in 2005 [11]. After masking variation in mobile genetic elements and repetitive regions,
we identified 268 single nucleotide polymorphisms (SNP) in the 3,770,610 basepair core
genome (S2 Table). Only a small fraction of mutations (i. e., 13 out of 268 SNPs) were detected
in close proximity (300 bp) to each other. After removal of these SNPs, the level of homo-
plasy was very low (homoplasy index, 0.019), suggesting that sequence variation had been gen-
erated primarily through mutations and that homologous recombination was rare. The
resulting set of 255 SNPs provided the basis for phylogenetic analyses.
A maximum-likelihood phylogenetic tree revealed two major clades (Fig 1). These clades
were identified as corresponding to the previously described strains of fluoroquinolone-
Phylogeography of Clostridium difficile 027
PLOSONE | DOI:10.1371/journal.pone.0139811 October 7, 2015 2 / 11
role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
resistant C. difficile 027, FQR1 and FQR2, by comparison to several genome sequences from
that previous study (Fig 1) [14]. This result demonstrated that both, FQR1 and FQR2, were
present in Germany. The majority of isolates in our sample (i. e., 51 out of 57) were related to
FQR2, however (Fig 1). As reported previously [14], all FQR1 and FQR2 isolates carried a mis-
sense mutation in their DNA gyrase subunit A gene that rendered them fluoroquinolone resis-
tant (S2 Table). In addition, one isolate from Germany (09–00072), which had been sampled in
1990 and was not resistant to fluoroquinolones, sat at a basal position in the tree and repre-
sented the ancestral ribotype 027 population, from which FQR1 and FQR2 have emerged (Fig
1, S1 Table) [14]. Bayesian phylogenetic analysis estimated that point mutations had accumu-
lated in the core genome of C. difficile 027 at an average rate of 0.17 mutations per 106 basepairs
per year (95% confidence intervals, 0.12 to 0.22 mutations per 106 basepairs per year), which is
similar to previous estimates [14, 21]. Based on this calibration, the emergence of FQR1 was
estimated to 1998 (95% confidence intervals, 1988 to 2001) and the emergence of FQR2 to
1997 (95% confidence intervals, 1987 to 2000), also in accordance with previous estimates [14].
Fig 1. Maximum likelihood phylogenetic tree. The phylogeny of C. difficile ribotype 027was reconstructed based on 255 core-genome SNPs. Previously
published genome sequences (indicated by shaded isolate names; [14]) were included to enable identification of clades FQR1 and FQR2. The tree was
rooted by using the distantly related BI 3 genome [14] as an outgroup.
doi:10.1371/journal.pone.0139811.g001
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The observed evolutionary rate of C. difficile is about 10-fold lower than for Staphylococcus
aureus [22–24] and some other bacteria [25], which limits the discriminatory power of C. diffi-
cile genome sequencing for molecular epidemiology analyses. Accordingly, and due to the sto-
chastic nature of spontaneous mutations, several groups of our isolates had core genome
sequences with no detectable differences, despite their temporal or spatial distances. For exam-
ple, we found identical genomes in five isolates which had been sampled over 19 months
(November 2008 to June 2010) in four different hospitals in Southern Germany (Stuttgart, Sin-
delfingen, Esslingen, Augsburg) (Fig 1, see 09–00077 and related isolates).
Phylogeographic analyses
For Bayesian phylogeographic inference, we analysed 66 FQR1 and FQR2 genomes, 56 of
which had been sampled from 35 geographic locations within Germany (S1 Table), and ten of
which originated from other countries (including the UK, USA, Canada, Switzerland, Korea,
[14]); the latter were included to place the C. difficile 027 population in Germany into an inter-
national context. Not unexpectedly, estimates of rates of spatial spread between pairs of these
35 locations yielded insufficient statistical support, because very few data points were available
for each individual estimate. Accordingly, discrete Bayes factor tests failed to verify transmis-
sions determined by the Markov chain Monte Carlo analysis (Bayes factors<3 for all individ-
ual transmissions, not shown). Therefore, to increase the statistical power of Bayesian
phylogeographic analysis, we grouped neighboring locations into regions based on their
straight-line distances (S1 Fig). When the number of locations was reduced to 17 regions in
Germany, Bayes factors were20 for individual transmissions within Germany (S5 Table),
which commonly is considered a significant level of support [26]. Further reduction to 11
regions in Germany yielded Bayes factors>290 for individual transmissions (S5 Table), indi-
cating strong support [26].
Dynamics of spatial spread
Independent from the level of parameter reduction, our phylogeographic analyses consistently
indicated four imports of fluoroquinolone-resistant C. difficile 027 into Germany (Fig 2, Fig 3,
S2 Fig and S3 Fig). These four introduction events were inferred from a Bayesian, time-cali-
brated phylogeny reconstruction (Fig 2) and their directionality was confirmed by Bayesian
stochastic search variable selection (BSSVS) (S5 Table) [27, 28]. Lineage FQR2 was indicated to
have been introduced into Southwestern Germany during the first half of 2005 (95% confi-
dence interval, 2001 to end of 2005) (Fig 2, Fig 3), hence some years before it caused a major
outbreak affecting several hospitals in the area around the city of Trier [16]. Our analysis con-
sidering 11 regions indicated the Saarland/Trier region as the first entry point for FQR2 (Fig 3),
and subsequent spread from there into the Rhein/Ruhr region, the Stuttgart region, and Thu-
ringia (Fig 3). In contrast, our analysis considering 17 regions (i. e., with moderate parameter
reduction) suggested the Stuttgart region as the first entry point (S2 Fig), hence this was not
clearly resolved. Interestingly, routine surveillance had detected fluoroquinolone-resistant C.
difficile 027 in a hospital in Stuttgart in January 2007 [15], simultaneously with the Trier out-
break [16]. In contrast to previous epidemiological analyses, however, our present analyses
consistently showed that, by the beginning of 2007, FQR2 had already been widespread in Ger-
many, affecting four regions in at least four different federal states (Fig 3). Phylogeographic
analysis also indicated that the FQR2 lineage was imported two more times, around 2006 and
2012, apparently into the Thuringia and Augsburg regions, respectively (Fig 3). Interestingly,
spread of FQR2 was restricted mostly to the West of Germany for several years and did not
reach Berlin and Saxony prior to 2009 (Fig 3). This finding is in concordance with the
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distribution of C. difficile 027 in German hospitals prior to 2009 as detected through epidemio-
logical surveillance [17]. In addition, FQR1 was imported around 2007 (95% HPD, 2004 to
Fig 2. Maximum clade credibility tree based on BEAST analysis of C. difficile genome sequences. Tips of the tree were constrained by sampling
dates, the time scale is shown at the bottom. Blue bars indicate 95% Bayesian credibility intervals of bacterial divergence dates (node heights).
doi:10.1371/journal.pone.0139811.g002
Fig 3. Bayesian reconstruction of the spread ofC. difficile 027 in Germany. Squares indicate the
centroids of 11 regions and lines indicate the inferred spread of FQR1 (blue) and FQR2 (red). Note that, in this
discrete analysis, arrival at a region centroid indicates arrival at that region, but trajectories do not represent
precise transport routes.
doi:10.1371/journal.pone.0139811.g003
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2009), yet its current distribution appears restricted to the East of Germany (i. e., we detected it
in the federal states of Sachsen and Thueringen; Fig 3, S1 Table). While available data is limited,
it appears from our results and from those of He et al. [14] that FQR1 is less prevalent than
FQR2, both in Germany and globally, even though they both emerged in North America
around the same time. Possibly, FQR1 is less proliferative than FQR2, but the reasons for this
difference have not been resolved.
Limitations
Even though our set of C. difficile isolates is the most comprehensive collection of C. difficile
ribotype 027 isolates from Germany studied to date, the number of isolates investigated
(n = 57) is very small compared to the number of hospitals or to annual numbers of CDI cases
[17, 20, 29]. Therefore, the scenario of C. difficile dissemination and spread we describe may
underestimate the complexity of the real situation. Because data available from isolates col-
lected internationally are even more limited [14], we did not attempt to identify sources for
introduction into Germany.
Conclusions
Genome-based phylogenetic analysis indicated that fluoroquinolone-resistant C. difficile ribo-
type 027 was imported into Germany at least four times independently. Despite the limited
number of isolates included and the comparatively low evolutionary rate of C. difficile, genome
re-sequencing provided conclusive information for Bayesian inference of spread between
regions within Germany based on a discrete phylogeographic model. Our analyses indicated
that one of the previously described fluoroquinolone-resistant variants of C. difficile 027 (i. e.,
FQR2) has spread within Germany for more than a decade, and the other variant (FQR1) had
been introduced few years later. At the time when the first outbreak of C. difficile 027 was
noticed in Germany in 2007 [16], these newly emerged strains had already been disseminated
across hospitals in several federal states, and they have continued to spread since then.
Methods and Tools
Isolates
Clostridium difficile ribotype 027 isolates (S1 Table) were selected based on results from classi-
cal ribotyping [17] or surface layer protein A sequence typing [30], respectively, and based on
their geographic origin, in order to achieve maximum representation of the pathogen's spatial
distribution in Germany. As a result, we included 57 C. difficile ribotype 027 isolates, collected
from hospitalized patients at 36 hospitals in Germany (S1 Table).
Ethics statement
A formal ethical review process and approval was not required in accordance with article 25,
section 1 of the German Infection Protection Act of 2001. All data were analyzed
anonymously.
Raw data
The genomes from C. difficile isolates were sequenced on HiScan and MiSeq systems (Illu-
mina), producing paired-end reads with lengths of 100 or 250 bases, respectively, to an average
>35-fold coverage. Sequencing data were submitted to the European Nucleotide Archive
(ENA) and assigned study accession number PRJEB9067. To enable comparisons to previously
published genome data [14], sequencing reads from representative FQR1 and FQR2 isolates
Phylogeography of Clostridium difficile 027
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(Fig 1) were downloaded from ENA and included in our analyses. Consensus sequences for
individual genomes were determined by applying a read mapping approach combining
BWA-SW version 0.7.3a [31] for mapping to a reference genome sequence (acc. no.
NC_013316 [32]), SAMtools [33] to handle SAM files (Sequence Alignment/Map) and VarS-
can (version 2.3) [34] for consensus calling in a customized pipeline framework (VarScan
parameters: minimum coverage, 10; minimum average base quality, 20; minimum variant fre-
quency, 0.8; p-value threshold, 0.01). The high-level interpreted language GNU Octave [35]
was used to format output files, to analyse the SNP content, and to assemble an alignment of
SNPs. Previously published sequencing reads from 11 C. difficile genomes were included for
reference [14](Fig 1).
Mobile genetic elements and repetitive sequences
Mobile genetic elements may evolve at a different mode and rate than the remainder of the
genome, and it is therefore wise to exclude them from phylogenetic analyses. To assort a list of
mobile genetic elements in the reference genome, the annotation was screened for keywords
and the web server based application PHAST [36] were used to identify mobile genetic ele-
ments [32, 37, 38], which were then excluded from phylogenetic analyses (S3 Table). We also
excluded CRISPR (S3 Table) and other repetitive DNA sequences, as they tend to create ambi-
guities in read alignments [39]. Repetitive DNA was detected with the pattern matching engine
available in KODON software (Applied Math).
Phylogenetic analyses
Phylogeny reconstruction is based on the assumption of tree-like evolution, which is violated
by homologous recombination that creates mosaic sequences [40]. Therefore we screened our
sequences for clustered variation and masked all mutations that had a distance of300 bp
from the next mutation. Based on an alignment of core-genome SNPs, PAUP 4b10 (http://
paup.csit.fsu.edu/) was used to calculate the homoplasy index, and PhyML implemented in
Seaview 4 was used to calculate a maximum-likelihood phylogenetic tree.
Bayesian inference with BEAST 2.0
To incorporate spatial and temporal components into the phylogeny, the BEAST 2.0 [41]
cross-platform was used. It implements a Bayesian framework focused on using strict or
relaxed molecular clock models for inference of time-measured phylogenies. As a total re-
implementation of the BEAST 1.x software package it provides the option to extend the system
with new models via the package system. BEAST 2.0 provides a full Bayesian framework for
phylogeographic analysis [27]. The model setup was done following the tutorial "Ancestral
reconstruction/discrete phylogeography with BEAST 2.0 (available at http://www.beast2.org/
wiki/index.php/Tutorials) with the BEAUti2 xml editor as a part of the BEAST 2.0 framework.
We used the beast-classic (BEAST_CLASSIC) add-on and the BEASTii add-on as described in
the tutorial. Each sequence was labeled with the year and month of isolate sampling and with
ETRS89 (European Terrestrial Reference System 1989) coordinates of sampling locations.
Using the HKY model of nucleotide substitution, a strict clock and an uncorrelated relaxed log-
normal clock model were tested. The initial clock rate was set to 2 x 10−7 substitutions per
nucleotide site and per year. On the prior for the nonzero rates (Poisson distribution), the
lambda (expected value, variance) was set to 100,693. To test the influence of several tree pri-
ors, analyses with different coalescent priors were applied in several runs, under the assump-
tion of a strict clock and an uncorrelated lognormal relaxed clock (S4 Table). For the combined
FQR1/FQR2 set without 09–00072 and BI–3 (66 sequences total), 6 x 107 generations was
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enough to verify proper mixing. Effective sample sizes (ESS) were>200. Trees from every
6,000 generations were sampled. To verify proper priors and to insure that the results are sig-
nificantly informed by the data, several runs with sampling from priors only were performed
and analysed. Samples from three independent Markov chain Monte Carlo runs were com-
bined by applying the LogCombiner software with an exclusion of 15% burn-in [41]. For
model comparison, Bayes factors were calculated based on marginal likelihood estimated by
using the smoothed harmonic mean estimator [42, 43], as implemented in the Tracer applica-
tion version v1.6.0.
Bayesian phylogeography
For discrete phylogeographic analysis, ETRS89 coordinates of sampling locations were incor-
porated into the model as an additional discrete location trait, applying the BEAST-classic add-
on during the model setup with BEAUti 2.0 as described by Lemey et al [27]. The Markov
chain Monte Carlo analysis was performed as described above, assuming an uncorrelated log-
normal relaxed clock and a coalescent constant tree prior. Effective sample sizes (ESS) were
>200. Tree files from three independent runs were combined and then processed with the
SPREAD 1.0.6 software (Spatial Phylogenetic Reconstruction of Evolutionary Dynamics) [28]
to determine the spatial spread in Germany. To identify well-supported transition rates, dis-
crete Bayes factor tests were performed on a BEAST log file with rate indicators (Bayesian sto-
chastic search variable selection (BSSVS) procedure; cutoff, 3) [27]. To increase the statistical
power of Bayesian phylogeographic inference, we grouped neighboring locations into regions
by using a hierarchical cluster analysis based on straight-line-distances and using the centroid
method assuming Euclidean metric (S1 Fig). Setting the level of hierarchy to reduce the num-
ber of locations is a compromise to maintain informative spatial resolution and ensure robust
statistics at the same time. This way, 11 or 17 regions, respectively, were defined to represent
the total of 35 locations in Germany from which isolates had originated, where each region was
represented by the coordinates of the centroid of the locations [44]. With these adjustments to
the priors, Markov chain Monte Carlo analysis was re-run, and the combined sample data
from three independent runs underwent discrete Bayes factor tests to verify the inferred transi-
tion rates S5 Table. The visualization of the proliferation dynamics of C. difficile in time and
space was derived from models assuming a relaxed clock.
Supporting Information
S1 Fig. Cluster analysis to group locations into 11 (A) or 17 (B) regions, respectively, based
on their distances from each other.
(TIF)
S2 Fig. Bayesian reconstruction of the spread of C. difficile 027 in Germany, considering 17
regions. Discrete phylogeographic analysis was performed with BEAST 2.0 and SPREAD 1.0.6.
(TIF)
S3 Fig. Bayesian reconstruction of the spread of C. difficile 027 in Germany, considering 35
locations. Discrete phylogeographic analysis was performed with BEAST 2.0 and SPREAD
1.0.6.
(TIF)
S1 Table. Bacterial isolates.
(XLSX)
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S2 Table. SNPs.
(XLSX)
S3 Table. Mobile genetic elements.
(XLSX)
S4 Table. Comparison of BEAST models. Clock rates and Bayes factor tests.
(XLSX)
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